drugset
drugset / Trial / NCT07708623

Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers

NCT07708623 ↗

Phase 1 Completed 18 enrolled Materia Medica Holding
NaSingle-groupOpen-labelTreatment

Summary

Open-label, non-comparative, non-randomized clinical trial of the safety and tolerability of the drug MMH-450 in healthy volunteers

Timeline

Start
2025-08-15
Primary completion
2025-12-10
Completion
2025-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MMH-450 Unknown — Oral

Indications

sleep disorder